BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 279 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,059,653 | +256.0% | 9,964 | +70.2% | 0.00% | – |
| Q3 2023 | $297,660 | -26.4% | 5,856 | -5.6% | 0.00% | – |
| Q2 2023 | $404,246 | -41.3% | 6,202 | -59.6% | 0.00% | -100.0% |
| Q1 2023 | $688,536 | -31.2% | 15,340 | -34.3% | 0.00% | 0.0% |
| Q4 2022 | $1,001,400 | -21.9% | 23,359 | +22.4% | 0.00% | -50.0% |
| Q3 2022 | $1,283,000 | -35.5% | 19,090 | -50.5% | 0.00% | -33.3% |
| Q2 2022 | $1,990,000 | +20.2% | 38,553 | +50.1% | 0.00% | +50.0% |
| Q1 2022 | $1,656,000 | +333.5% | 25,681 | +593.9% | 0.00% | – |
| Q3 2021 | $382,000 | -29.8% | 3,701 | -40.1% | 0.00% | -100.0% |
| Q2 2021 | $544,000 | +28.9% | 6,179 | +41.3% | 0.00% | – |
| Q1 2021 | $422,000 | -50.6% | 4,372 | -42.6% | 0.00% | -100.0% |
| Q4 2020 | $854,000 | +258.8% | 7,620 | +202.3% | 0.00% | – |
| Q2 2019 | $238,000 | +7.2% | 2,521 | -9.2% | 0.00% | – |
| Q1 2019 | $222,000 | – | 2,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |